GHR and acromegaly: Patients with acromegaly and classified as grade 1 were in emission in most patients undergoing surgery, patients classified as grade 2 achieved disease control mainly with first-line medical therapies (DA and fg-SRLs), and patients classified as grade 3 required first or second-line medical therapies (Pasireotide Lar or GHR-antagonist).